coldchain_liu

TL3 Regular · Vancouver, CA

Cold chain validation for clinical supplies. Phase-change packs, mean kinetic temperature, and why a warm parcel is not automatically a ruined one.

Joined 12 December 2024 · last posted 5d · groups: wiki-editors

138 posts, newest first. Showing up to 150.

Programming during a large energy deficit Replied, post #47 · Nutrition & Training › Resistance training · 23 Jul 2026 · 10 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Immortal time bias in a claims-database study — one year on Replied, post #36 · Evidence › Study critique · 21 Jul 2026 · 0 likes Per-protocol and intention-to-treat analyses answer different questions and neither is the honest one by default. Reporting both is the practice worth insisting on.
Seven-day rolling means and why weekly readings mislead Replied, post #56 · Outcomes › Progress reports · 18 Jul 2026 · 0 likes Seven-day rolling has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
Why the timeline is on the right and not the left — what changed since Replied, post #76 · Meta › Site feedback · 17 Jul 2026 · 0 likes On post #75 — agreed on the reasoning, with one qualification. What would change my mind on timeline is a second dataset collected by someone with no stake in the…
A site rotation scheme that is easy enough to actually follow Replied, post #117 · Practice › Administration · 17 Jul 2026 · 16 likes This follows post #114 rather than contradicting it. If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for…
What to bring: records that a clinician can actually use Replied, post #3 · Clinical › Prescriber conversations · 16 Jul 2026 · 11 likes Adding the measurement that post #2 says would settle it. A question phrased as "what would you want to see before considering X" is answerable and is not a request for…
Follow-up: UK access routes, dated and sourced Replied, post #12 · Regional › UK & Ireland · 16 Jul 2026 · 6 likes Post #11 is right about the mechanism and I think understates the practical bit. MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #39 · Analytics › HPLC & UHPLC · 15 Jul 2026 · 1 like Carryover from a previous injection shows up as a small peak at the same retention time in a blank. A method report that includes a blank injection is telling you the…
Deletion sequences: expected mass shifts by residue — the long version Replied, post #12 · Analytics › Impurities & related substances · 15 Jul 2026 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
Semaglutide and alcohol: what is actually documented Replied, post #16 · Compounds › Semaglutide · 13 Jul 2026 · 29 likes That is a cleaner way of putting what I was circling around.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #63 · Evidence › Journal club · 11 Jul 2026 · 2 likes The arithmetic in post #61 is right; the assumption feeding it is the part to check. The figures usually contain the finding and the text usually contains the…
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #20 · Compounds › Repair & healing peptides · 8 Jul 2026 · 16 likes I had written a reply contradicting post #16 and deleted it. Here is what survived. BPC-157's published evidence is overwhelmingly preclinical and mostly rodent. That…
Does a peptide degrade silently, with no visual change? Replied, post #63 · Practice › Storage & stability · 5 Jul 2026 · 28 likes Where I part company with post #61, and it is a narrow parting. Adsorption to container surfaces removes peptide from solution without changing how the solution looks.…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #38 · Compounds › Retatrutide · 5 Jul 2026 · 33 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
A 10 mg vial reconstituted three different ways, compared Replied, post #30 · Practice › Reconstitution · 4 Jul 2026 · 15 likes Post #29 put the caveat in the right place and I want to underline it. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL,…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #94 · Analytics › HPLC & UHPLC · 1 Jul 2026 · 18 likes Post #92 and I disagree about the size of the effect, not about the direction. A request rather than an answer: could whoever has the primary source for Carryover post…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #43 · Analytics › Home & field testing · 1 Jul 2026 · 13 likes Practical experience of consumer-accessible tests, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #32 · Analytics › Home & field testing · 27 Jun 2026 · 13 likes I read post #30 twice before replying, because I had assumed the opposite. Colorimetric tests: colour intensity correlates with concentration, but the relationship is…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #75 · Analytics › HPLC & UHPLC · 26 Jun 2026 · 0 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #22 · Analytics › Impurities & related substances · 24 Jun 2026 · 0 likes Adding the measurement that post #19 says would settle it. Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography,…
Spreadsheets: an appreciation — what changed since Replied, post #79 · Lounge › Off topic · 23 Jun 2026 · 24 likes Unserious but true: I can now identify a certificate template at a glance and I have no professional use for that skill whatsoever.
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #12 · Practice › Dosing & titration · 23 Jun 2026 · 27 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
A site rotation scheme that is easy enough to actually follow Replied, post #95 · Practice › Administration · 22 Jun 2026 · 30 likes Post #91 put the caveat in the right place and I want to underline it. If you have to inject at a different time of day than usual, that is a much smaller perturbation…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #123 · Practice › Reconstitution · 22 Jun 2026 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
Submitting a sample: the process end to end Replied, post #31 · Sourcing › Independent verification · 22 Jun 2026 · 11 likes Answering the question post #29 raises rather than the one it answers. The bit of submitting a sample that nobody enjoys is that the answer changes depending on what…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #27 · Compounds › Secretagogues & GH axis · 20 Jun 2026 · 19 likes That is a cleaner way of putting what I was circling around.
Revisiting: What pooling buys you and what it destroys Replied, post #56 · Evidence › Meta-analyses · 15 Jun 2026 · 31 likes Narrowing post #55, because the general version has more than one answer. The practical version of pooling buys is three sentences long. The rigorous version is three…
Cold solution and stinging: the simplest fix Replied, post #34 · Practice › Administration · 11 Jun 2026 · 12 likes Appreciated. The plain phrasing does more work here than a longer post would.
Constipation management, with a dietitian's contribution Replied, post #77 · Practice › Side effects · 10 Jun 2026 · 1 like The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
When a dose reduction is the correct response to a side effect Replied, post #27 · Practice › Dosing & titration · 6 Jun 2026 · 19 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
What to include when your question involves a chromatogram — one year on Replied, post #28 · Start Here › How to Ask · 6 Jun 2026 · 0 likes Where I part company with post #26, and it is a narrow parting. Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post,…
Injecting into an area that has become firm: why not to Replied, post #3 · Practice › Administration · 1 Jun 2026 · 10 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. That…
Step therapy requirements and how to satisfy them Replied, post #25 · Access › Insurance & coverage · 25 May 2026 · 0 likes On step therapy requirements, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #66 · Compounds › Tirzepatide · 19 May 2026 · 16 likes Adding a small correction to the Tirzepatide and nausea summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor…
What a certificate commits its issuer to — the long version Replied, post #4 · Analytics › COA interpretation · 1 May 2026 · 0 likes Answering the question the opening post raises rather than the one it answers. "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A…
The most useful thing you learned here that was not the answer you came for Replied, post #37 · Lounge › Off topic · 24 Apr 2026 · 22 likes Since the Lounge tolerates a digression: the thing I find most interesting about this community is how much of the useful material is negative. Half the value is…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #45 · Practice › Administration · 10 Apr 2026 · 0 likes Needle length matters less than angle for subcutaneous delivery in most people. A short needle at ninety degrees and a longer one at forty-five put the material in…
Revisiting: Drawing up with one needle and injecting with another Replied, post #60 · Practice › Administration · 6 Apr 2026 · 9 likes Post #56 describes the usual case. This is about the unusual one. Drawing up with one needle and injecting with another: a reasonable practice if you have extra…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #32 · Compounds › Repair & healing peptides · 4 Apr 2026 · 0 likes Post #30 answers the question as asked. The question underneath it is different. Distinguishing three things in the Stability of BPC-157 discussion that keep getting…
Grapefruit: why this class is not the class that cares Replied, post #81 · Practice › Interactions · 26 Mar 2026 · 14 likes Where I part company with post #79, and it is a narrow parting. Anticoagulant questions come up regularly and are the clearest case for professional advice rather than…
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #4 · Compounds › Oral incretins · 23 Mar 2026 · 0 likes Coming back to post #3, because the follow-up matters more than the original answer. Taking the oral product with more water than instructed reduces absorption rather…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #34 · Practice › Administration · 22 Mar 2026 · 19 likes This follows post #33 rather than contradicting it. Filing a mild objection to the consensus on Pinch. Mild because I might be wrong; an objection because nobody has…
The "under review" status pill and when a moderator applies it Replied, post #21 · Evidence › Preprints · 15 Mar 2026 · 0 likes Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one, the preprint can be genuinely useful.
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #53 · Lounge › Introductions · 13 Mar 2026 · 2 likes What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #37 · Practice › Administration · 13 Mar 2026 · 6 likes Bookmarking this. I will come back when I have something worth adding.
Guidelines revision: what changed and why — one year on Replied, post #81 · Meta › Announcements · 12 Mar 2026 · 0 likes The arithmetic in post #78 is right; the assumption feeding it is the part to check. Nobody has said the unglamorous part of Guidelines revision yet, so: most of the…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #12 · Meta › Announcements · 5 Mar 2026 · 0 likes A request rather than an answer: could whoever has the primary source for Trust level 3 requirements post it? I have seen the claim three times this month and each…
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #5 · Practice › Dosing & titration · 3 Mar 2026 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
What I would record differently if I started again Replied, post #2 · Outcomes › Progress reports · 3 Mar 2026 · 11 likes Answering the question the opening post raises rather than the one it answers. Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #24 · Research Methods › N-of-1 designs · 1 Mar 2026 · 19 likes On post #22 — agreed on the reasoning, with one qualification. The most useful reply I ever got about ABAB design was a request to state my units. It sounds like…
Research-use-only status: what it means legally and practically Replied, post #7 · Compounds › Other compounds · 22 Feb 2026 · 4 likes Post #5 put the caveat in the right place and I want to underline it. Something worth flagging about research-use-only status: the strongest-sounding claims in this…
Personal import allowances, compared — a second dataset Replied, post #73 · Access › International · 22 Feb 2026 · 0 likes I would put moderate confidence on the mainstream reading of Personal import allowances and no more. That is not scepticism for its own sake; it is where the sourcing…
Coming back to: Time to steady state after a dose increase Replied, post #4 · Pharmacology › Pharmacokinetics · 21 Feb 2026 · 2 likes A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #117 · Practice › Dosing & titration · 21 Feb 2026 · 0 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
Anaesthesia and elective surgery: the aspiration question Replied, post #27 · Practice › Interactions · 20 Feb 2026 · 9 likes Post #26 answers the question as asked. The question underneath it is different. Mechanistic reasoning about interactions has a poor predictive record. It is a good way…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #72 · Outcomes › Progress reports · 17 Feb 2026 · 1 like Narrowing post #69, because the general version has more than one answer. Maintenance series are the ones this subcategory needs most and receives least. The…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #14 · Practice › Dosing & titration · 15 Feb 2026 · 12 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
Trifluoroacetate content and its consequences Replied, post #111 · Analytics › Impurities & related substances · 8 Feb 2026 · 17 likes Second-hand on trifluoroacetate content, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
Trifluoroacetate content and its consequences Replied, post #106 · Analytics › Impurities & related substances · 8 Feb 2026 · 2 likes Where I part company with post #104, and it is a narrow parting. Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting…
Personal import allowances, compared — a second dataset Replied, post #64 · Access › International · 6 Feb 2026 · 16 likes Where a jurisdiction has published guidance for clinicians, that document usually answers the practical questions better than any consumer-facing page.
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #74 · Pharmacology › Pharmacokinetics · 3 Feb 2026 · 24 likes I keep a log for Half-life specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.
Heterogeneity as information rather than as a nuisance Replied, post #77 · Evidence › Meta-analyses · 26 Jan 2026 · 8 likes Small correction to my own earlier position on heterogeneity. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore…
Coming back to: Pen dose counters: what a click does and does not guarantee Replied, post #4 · Devices › Pens & autoinjectors · 26 Jan 2026 · 4 likes Disposal of a used pen is a sharps question even where the needle is retracted, and local rules vary more than people expect.
Follow-up: Search filters: what is missing Replied, post #19 · Meta › Site feedback · 22 Jan 2026 · 13 likes On post #15 — agreed on the reasoning, with one qualification. Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #62 · Pharmacology › Receptor biology · 17 Jan 2026 · 12 likes Long-term receptor changes: very little is known about what happens to receptor expression, signalling, and downstream effects over years of exposure to these…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #53 · Analytics › Method validation · 7 Jan 2026 · 18 likes Post #51 and I disagree about the size of the effect, not about the direction. Range and working range are different things and a certificate rarely distinguishes them.…
Reading SURMOUNT-1 without the press release — one year on Replied, post #34 · Compounds › Tirzepatide · 30 Dec 2025 · 31 likes SURMOUNT-4's randomised withdrawal design is the strongest available evidence about what happens on stopping. It says nothing about a lower maintenance dose, because…
Storing lyophilised material long term: what governs the shelf life Replied, post #5 · Practice › Storage & stability · 24 Dec 2025 · 4 likes I have no financial interest in anything named in this thread and I want to say so before I comment on storing lyophilised material long term, because it is the sort of…
Prescription requirements and telehealth models Replied, post #85 · Sourcing › Regulatory · 23 Dec 2025 · 12 likes Post #83 put the caveat in the right place and I want to underline it. For anyone finding this later: the short answer on prescription requirements and telehealth…
Early satiety becoming a problem rather than a benefit Replied, post #12 · Practice › Side effects · 1 Dec 2025 · 0 likes Severe, persistent abdominal pain, especially radiating to the back, is in a different category from ordinary gastrointestinal upset and is a reason to seek medical…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #23 · Access › Pricing · 25 Nov 2025 · 0 likes I would put moderate confidence on the mainstream reading of Price changes and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
Robustness: the parameters worth deliberately varying Replied, post #19 · Analytics › Method validation · 24 Nov 2025 · 0 likes Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one. This is where my knowledge…
What pooling buys you and what it destroys Replied, post #68 · Evidence › Meta-analyses · 16 Nov 2025 · 11 likes Agreed on all of that, and I have nothing to add to it.
Sleep quality changes during weight loss — what changed since Replied, post #62 · Wellbeing › Sleep · 13 Nov 2025 · 26 likes The published data on sleep outcomes in this class is thinner than the volume of discussion, which is worth saying plainly. That is where I would start, not where I…
Reading SURMOUNT-1 without the press release Replied, post #57 · Compounds › Tirzepatide · 6 Nov 2025 · 0 likes Answering the question post #54 raises rather than the one it answers. A note on scope: what I am saying about reading SURMOUNT-1 without the press applies to the case…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #50 · Compounds › Tirzepatide · 21 Oct 2025 · 2 likes Post #46 put the caveat in the right place and I want to underline it. SURMOUNT-4 is one of those subjects where the general answer and the answer for a specific case…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #55 · Compounds › Other compounds · 26 Sep 2025 · 1 like Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #104 · Compounds › Oral incretins · 19 Sep 2025 · 20 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
Reading SURMOUNT-1 without the press release Replied, post #2 · Compounds › Tirzepatide · 3 Sep 2025 · 0 likes Practical answer on reading SURMOUNT-1 without the press, since the theoretical one is upthread: do the simplest check first, write down the result, and only then…
When a preprint is the best available evidence and we say so Replied, post #63 · Evidence › Preprints · 16 Aug 2025 · 0 likes Version numbers on a preprint server matter. Citing version one of something now on version four is citing a document that has been superseded by its own authors. Happy…
[2026 update] Heterogeneity as information rather than as a nuisance Replied, post #5 · Evidence › Meta-analyses · 14 Aug 2025 · 0 likes The I-squared statistic describes the proportion of variability not attributable to chance and is frequently read as a threshold. It is a description rather than a…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #105 · Compounds › Tirzepatide · 13 Aug 2025 · 31 likes Confirming post #102 from a second method, which matters more than confirming it from a second person. The dual agonism is not a marketing framing — GIP receptor and…
Distinguishing a deletion sequence by mass alone — the long version Replied, post #39 · Analytics › Mass spectrometry · 8 Aug 2025 · 1 like Response in electrospray is not proportional to abundance across different species. Using peak intensities from a mass spectrum to estimate proportions is a mistake…
EU-wide position versus national implementation Replied, post #19 · Regional › European Union · 20 Jul 2025 · 26 likes Adding a note of thanks rather than an opinion. I did not know most of that.
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #48 · Data & Tools › Calculators · 11 Jul 2025 · 16 likes Significant figures in the output should not exceed what the inputs support. A concentration calculated from a nominal vial mass is not known to four decimal places. It…
Pages past their review date, listed Started this topic · Meta › Wiki maintenance · 24 Jun 2025 · 29 likes Pages past their review date, listed Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on pages past. It is…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #56 · Evidence › Journal club · 22 Jun 2025 · 12 likes I read the earlier replies on SURMOUNT-4 and continuation versus withdrawal twice before writing this, because I had assumed the opposite and wanted to be sure I was…
Why the timeline is on the right and not the left Replied, post #31 · Meta › Site feedback · 20 Jun 2025 · 28 likes Post #28 describes the usual case. This is about the unusual one. That would also be the fastest way for a new member to understand what R6 actually catches, which is…
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #33 · Compounds › Semaglutide · 19 Jun 2025 · 11 likes Post #32 answers the question as asked. The question underneath it is different. Injection site does not appear to matter much for semaglutide exposure. The published…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #40 · Pharmacology › Pharmacokinetics · 11 Jun 2025 · 6 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
Counter-ion content and its effect on measured mass Replied, post #54 · Analytics › Mass spectrometry · 2 Jun 2025 · 14 likes A mass match establishes that the measured mass is consistent with the proposed composition. It does not establish purity, sequence order, or the absence of an isomer,…
Regression to the mean in progress reports Replied, post #13 · Research Methods › Statistics · 25 May 2025 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #24 · Clinical › Bloodwork · 24 May 2025 · 18 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
Reading a trial's population section before its results — does this still hold? Replied, post #136 · Evidence › Trials · 23 May 2025 · 6 likes Confirming post #135 from a second method, which matters more than confirming it from a second person. The first question about any trial is what it set out to…
Second pass at: Designing a personal experiment that could change your mind Replied, post #45 · Research Methods › N-of-1 designs · 22 May 2025 · 13 likes Post #43 put the caveat in the right place and I want to underline it. The question underneath Designing a personal experiment is usually "how would I tell?" rather…
Travel coolers and how long they really hold — the long version Replied, post #7 · Devices › Cold chain · 20 May 2025 · 0 likes The useful distinction on Travel coolers is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #30 · Evidence › Trials · 15 May 2025 · 17 likes Picking up post #27: that is the part I would want checked first. The useful distinction on Comparators chosen for regulatory reasons is between what was measured and…
A supplier that answers analytical questions with restated claims Replied, post #69 · Sourcing › Red flags · 3 May 2025 · 1 like Narrowing post #68, because the general version has more than one answer. The guidelines draw that line for a practical reason as much as a fair one: reports accumulate…
Relative retention time as a better inter-laboratory comparator Replied, post #5 · Analytics › Method validation · 28 Apr 2025 · 15 likes Having read the whole relative retention time thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a…
EU-wide position versus national implementation Replied, post #2 · Regional › European Union · 27 Apr 2025 · 8 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #133 · Evidence › Journal club · 23 Apr 2025 · 24 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
Requesting a page: what makes a good request Replied, post #60 · Documentation › Wiki requests · 17 Apr 2025 · 0 likes Coming back to post #56, because the follow-up matters more than the original answer. A request is more likely to succeed with a proposed outline attached. "Somebody…
Validating a calculator against hand arithmetic — what changed since Replied, post #18 · Data & Tools › Calculators · 15 Apr 2025 · 14 likes A calculator that shows its working is worth ten that give an answer. The whole value is being able to see which step you disagree with. Reporting the observation and…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #41 · Compounds › Secretagogues & GH axis · 12 Apr 2025 · 0 likes Having read the whole Tesamorelin thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #12 · Evidence › Journal club · 6 Apr 2025 · 4 likes Narrowing post #9, because the general version has more than one answer. I disagree with the framing of SURMOUNT-4 and continuation versus withdrawal above, and I think…
Talking to a therapist about this specifically — does this still hold? Replied, post #40 · Wellbeing › Mental health · 5 Apr 2025 · 0 likes Coming back to post #36, because the follow-up matters more than the original answer. Where a member is finding this hard, the useful reply is usually a question rather…
Adducts: sodium, potassium, and the peak you did not expect Replied, post #48 · Analytics › Mass spectrometry · 28 Mar 2025 · 21 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
Follow-up: Review cadence: how often is a page actually re-checked? Replied, post #2 · Documentation › Doc review · 27 Mar 2025 · 3 likes Building on the opening post rather than restating it. Where the review finds the content is right but the framing overstates it, that is the most valuable catch…
Counter-ion form: the field almost nobody reports — one year on Replied, post #114 · Analytics › COA interpretation · 23 Mar 2025 · 8 likes Reading this Counter-ion form thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
One lot is one lot: when a report becomes a pattern — the long version Replied, post #113 · Sourcing › Vendor reports · 18 Mar 2025 · 12 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable. A single observation, in a thread that…
Journal club: SURMOUNT-1, read without the press release Replied, post #77 · Evidence › Journal club · 14 Mar 2025 · 0 likes Answering the SURMOUNT-1 question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
Scheduled maintenance and what will be unavailable Replied, post #64 · Meta › Announcements · 6 Mar 2025 · 1 like That is clearer than the version I had in my head. Thank you.
Follow-up: What other technical communities get right that we do not Replied, post #31 · Lounge › Off topic · 4 Mar 2025 · 7 likes Something I have wondered without ever asking: is there a good reason the vocabulary in this field is so inconsistent between suppliers? Half the disagreements here…
Consistent declarations and why they matter more than clever ones Replied, post #80 · Sourcing › Logistics · 24 Feb 2025 · 0 likes The honest answer on consistent declarations is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they…
Consistent declarations and why they matter more than clever ones Replied, post #65 · Sourcing › Logistics · 21 Feb 2025 · 9 likes Where I part company with post #63, and it is a narrow parting. I disagree with the framing of consistent declarations above, and I think it is a substantive…
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #45 · Compounds › Secretagogues & GH axis · 20 Feb 2025 · 2 likes The strongest argument against my own position on pulsatile secretion, stated as well as I can state it, since nobody else has yet.
A promotion I argued against, and why I lost Replied, post #99 · Documentation › Doc review · 16 Feb 2025 · 0 likes The most useful review comment names a sentence and says what is wrong with it. General approval and general concern are both hard to act on.
Reconstituting a multi-strength kit without mixing yourself up Replied, post #28 · Practice › Reconstitution · 2 Feb 2025 · 12 likes Building on post #25 rather than restating it. Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #54 · Compounds › Cagrilintide & amylin analogues · 22 Jan 2025 · 11 likes One more thing on amylin analogue mechanism that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that,…
When to suspect the method rather than the sample Replied, post #68 · Analytics › Method validation · 19 Jan 2025 · 16 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number. Posted…
Recovery when intake is low: what to cut first Replied, post #62 · Nutrition & Training › Resistance training · 13 Jan 2025 · 0 likes Nobody has said the unglamorous part of recovery yet, so: most of the variation is explained by things that are boring to write about and easy to check.
Follow-up: Individual participant data versus aggregate data Replied, post #56 · Evidence › Meta-analyses · 10 Jan 2025 · 30 likes Where I part company with post #54, and it is a narrow parting. Double extraction with disagreement resolution is standard and is worth checking for, because single…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #154 · Compounds › Oral incretins · 29 Dec 2024 · 25 likes Understood, and I withdraw the assumption I opened with.
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #74 · Compounds › Semaglutide · 23 Dec 2024 · 0 likes The practical version of Molecular mass of semaglutide is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #158 · Analytics › COA interpretation · 20 Dec 2024 · 2 likes Offering a way to settle field-by-field walk through a certificate rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the…
Body image changing more slowly than the body Replied, post #62 · Wellbeing › Mental health · 18 Dec 2024 · 27 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
[2026 update] Step therapy requirements and how to satisfy them Replied, post #74 · Access › Insurance & coverage · 17 Dec 2024 · 26 likes Worth separating two things that post #70 runs together. A note on how Step therapy requirements gets discussed rather than on Step therapy requirements itself: the…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #57 · Evidence › Journal club · 11 Dec 2024 · 32 likes This is the sort of exchange that makes the archive worth searching.
Fibre intake when total intake falls, and the constipation link Replied, post #3 · Nutrition & Training › Protein & intake · 29 Nov 2024 · 2 likes Worth separating two things that the opening post runs together. Tracking intake for a week rather than permanently is usually enough to find out whether there is a…
Revisiting: Moderation log format change Replied, post #43 · Meta › Announcements · 26 Nov 2024 · 0 likes The moderation log will carry the announcement entry, so the date is recoverable. It will not be visible on the topic itself, which is probably the right level of…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #20 · Clinical › Special populations · 20 Nov 2024 · 8 likes What I would check first on Type 1 diabetes is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
EMA product information as a primary source — does this still hold? Replied, post #117 · Regional › European Union · 18 Nov 2024 · 20 likes One caution on EMA product information: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely…
EMA product information as a primary source — does this still hold? Replied, post #81 · Regional › European Union · 17 Nov 2024 · 0 likes EMA product information looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
EMA product information as a primary source — does this still hold? Replied, post #62 · Regional › European Union · 16 Nov 2024 · 3 likes Thank you for the correction. I would rather find out here than later.
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #24 · Compounds › Semaglutide · 13 Nov 2024 · 10 likes No notes. Posting so the count is not one.
Why "any advice?" is the least effective ending for a post Replied, post #13 · Start Here › How to Ask · 6 Nov 2024 · 12 likes Agreed on all of that, and I have nothing to add to it.
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #17 · Sourcing › Regulatory · 30 Oct 2024 · 0 likes Confirming post #16 from a second method, which matters more than confirming it from a second person. The claim about Research-use-only labelling upthread is stronger…
Second pass at: Journal club: LEADER as the historical anchor Replied, post #3 · Evidence › Journal club · 5 Jul 2024 · 0 likes The version of LEADER that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and those…